vs
Martin Marietta Materials（MLM）与百利高（PRGO）财务数据对比。点击上方公司名可切换其他公司
Martin Marietta Materials的季度营收约是百利高的1.0倍（$1.1B vs $1.1B），Martin Marietta Materials净利率更高（24.5% vs -127.8%，领先152.3%），百利高同比增速更快（-2.5% vs -30.1%），Martin Marietta Materials自由现金流更多（$424.0M vs $148.6M），过去两年百利高的营收复合增速更高（1.3% vs -4.5%）
马丁·玛丽埃塔材料公司是美国大型集料及重型建筑材料供应商，业务覆盖美国26个州、加拿大及加勒比地区，主要为道路、人行道、地基等各类基建项目提供所需原材料。
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
MLM vs PRGO — 直观对比
营收规模更大
MLM
是对方的1.0倍
$1.1B
营收增速更快
PRGO
高出27.6%
-30.1%
净利率更高
MLM
高出152.3%
-127.8%
自由现金流更多
MLM
多$275.4M
$148.6M
两年增速更快
PRGO
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.1B |
| 净利润 | $279.0M | $-1.4B |
| 毛利率 | 35.0% | 32.6% |
| 营业利润率 | 24.6% | -116.0% |
| 净利率 | 24.5% | -127.8% |
| 营收同比 | -30.1% | -2.5% |
| 净利润同比 | -4.8% | -3093.9% |
| 每股收益（稀释后） | $4.59 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLMPRGO
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.8B | $1.0B | ||
| Q2 25 | $1.8B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.9B | $1.1B | ||
| Q2 24 | $1.8B | $1.1B | ||
| Q1 24 | $1.3B | $1.1B |
净利润MLMPRGO
| Q4 25 | $279.0M | $-1.4B | ||
| Q3 25 | $414.0M | $7.5M | ||
| Q2 25 | $328.0M | $-8.4M | ||
| Q1 25 | $116.0M | $-6.4M | ||
| Q4 24 | $293.0M | $-44.4M | ||
| Q3 24 | $363.0M | $-21.0M | ||
| Q2 24 | $294.0M | $-108.4M | ||
| Q1 24 | $1.0B | $2.0M |
毛利率MLMPRGO
| Q4 25 | 35.0% | 32.6% | ||
| Q3 25 | 33.1% | 36.1% | ||
| Q2 25 | 30.0% | 34.4% | ||
| Q1 25 | 24.8% | 37.6% | ||
| Q4 24 | 30.0% | 33.9% | ||
| Q3 24 | 31.7% | 37.2% | ||
| Q2 24 | 29.3% | 37.0% | ||
| Q1 24 | 21.7% | 33.1% |
营业利润率MLMPRGO
| Q4 25 | 24.6% | -116.0% | ||
| Q3 25 | 27.4% | 7.0% | ||
| Q2 25 | 25.3% | 4.3% | ||
| Q1 25 | 14.3% | 4.5% | ||
| Q4 24 | 24.4% | 10.0% | ||
| Q3 24 | 25.9% | 7.4% | ||
| Q2 24 | 22.6% | -2.5% | ||
| Q1 24 | — | -5.1% |
净利率MLMPRGO
| Q4 25 | 24.5% | -127.8% | ||
| Q3 25 | 22.4% | 0.7% | ||
| Q2 25 | 18.1% | -0.8% | ||
| Q1 25 | 8.6% | -0.6% | ||
| Q4 24 | 18.0% | -3.9% | ||
| Q3 24 | 19.2% | -1.9% | ||
| Q2 24 | 16.7% | -10.2% | ||
| Q1 24 | 83.5% | 0.2% |
每股收益（稀释后）MLMPRGO
| Q4 25 | $4.59 | $-10.23 | ||
| Q3 25 | $6.85 | $0.05 | ||
| Q2 25 | $5.43 | $-0.06 | ||
| Q1 25 | $1.90 | $-0.05 | ||
| Q4 24 | $4.87 | $-0.32 | ||
| Q3 24 | $5.91 | $-0.15 | ||
| Q2 24 | $4.76 | $-0.79 | ||
| Q1 24 | $16.87 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.0M | — |
| 总债务越低越好 | $5.3B | — |
| 股东权益账面价值 | $10.0B | $2.9B |
| 总资产 | $18.7B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.53× | — |
8季度趋势，按日历期对齐
现金及短期投资MLMPRGO
| Q4 25 | $67.0M | — | ||
| Q3 25 | $57.0M | $432.1M | ||
| Q2 25 | $225.0M | $454.2M | ||
| Q1 25 | $101.0M | $409.9M | ||
| Q4 24 | $670.0M | $558.8M | ||
| Q3 24 | $52.0M | $1.5B | ||
| Q2 24 | $109.0M | $542.8M | ||
| Q1 24 | $2.6B | $658.5M |
总债务MLMPRGO
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.5B | — | ||
| Q2 25 | $5.4B | — | ||
| Q1 25 | $5.4B | — | ||
| Q4 24 | $5.4B | — | ||
| Q3 24 | $4.0B | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.3B | — |
股东权益MLMPRGO
| Q4 25 | $10.0B | $2.9B | ||
| Q3 25 | $9.7B | $4.4B | ||
| Q2 25 | $9.4B | $4.5B | ||
| Q1 25 | $9.1B | $4.4B | ||
| Q4 24 | $9.5B | $4.3B | ||
| Q3 24 | $9.2B | $4.6B | ||
| Q2 24 | $8.8B | $4.5B | ||
| Q1 24 | $8.9B | $4.7B |
总资产MLMPRGO
| Q4 25 | $18.7B | $8.5B | ||
| Q3 25 | $18.7B | $10.1B | ||
| Q2 25 | $18.1B | $10.1B | ||
| Q1 25 | $17.7B | $9.8B | ||
| Q4 24 | $18.2B | $9.6B | ||
| Q3 24 | $16.5B | $11.2B | ||
| Q2 24 | $16.3B | $10.4B | ||
| Q1 24 | $16.2B | $10.6B |
负债/权益比MLMPRGO
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.57× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 0.60× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $629.0M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | $424.0M | $148.6M |
| 自由现金流率自由现金流/营收 | 37.2% | 13.4% |
| 资本支出强度资本支出/营收 | 18.0% | 2.4% |
| 现金转化率经营现金流/净利润 | 2.25× | — |
| 过去12个月自由现金流最近4个季度 | $978.0M | $145.1M |
8季度趋势，按日历期对齐
经营现金流MLMPRGO
| Q4 25 | $629.0M | $175.4M | ||
| Q3 25 | $551.0M | $51.7M | ||
| Q2 25 | $387.0M | $75.9M | ||
| Q1 25 | $218.0M | $-64.5M | ||
| Q4 24 | $686.0M | $312.6M | ||
| Q3 24 | $600.0M | $42.2M | ||
| Q2 24 | $1.0M | $9.5M | ||
| Q1 24 | $172.0M | $-1.4M |
自由现金流MLMPRGO
| Q4 25 | $424.0M | $148.6M | ||
| Q3 25 | $361.0M | $29.8M | ||
| Q2 25 | $208.0M | $56.7M | ||
| Q1 25 | $-15.0M | $-90.0M | ||
| Q4 24 | $453.0M | $274.9M | ||
| Q3 24 | $317.0M | $15.1M | ||
| Q2 24 | $-138.0M | $-18.9M | ||
| Q1 24 | $-28.0M | $-26.5M |
自由现金流率MLMPRGO
| Q4 25 | 37.2% | 13.4% | ||
| Q3 25 | 19.6% | 2.9% | ||
| Q2 25 | 11.5% | 5.4% | ||
| Q1 25 | -1.1% | -8.6% | ||
| Q4 24 | 27.8% | 24.2% | ||
| Q3 24 | 16.8% | 1.4% | ||
| Q2 24 | -7.8% | -1.8% | ||
| Q1 24 | -2.2% | -2.4% |
资本支出强度MLMPRGO
| Q4 25 | 18.0% | 2.4% | ||
| Q3 25 | 10.3% | 2.1% | ||
| Q2 25 | 9.9% | 1.8% | ||
| Q1 25 | 17.2% | 2.4% | ||
| Q4 24 | 14.3% | 3.3% | ||
| Q3 24 | 15.0% | 2.5% | ||
| Q2 24 | 7.9% | 2.7% | ||
| Q1 24 | 16.0% | 2.3% |
现金转化率MLMPRGO
| Q4 25 | 2.25× | — | ||
| Q3 25 | 1.33× | 6.89× | ||
| Q2 25 | 1.18× | — | ||
| Q1 25 | 1.88× | — | ||
| Q4 24 | 2.34× | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.16× | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLM
| Building Materials Business East Group | $774.0M | 68% |
| Building Materials Business West Group | $233.0M | 20% |
| Services | $88.0M | 8% |
| Other | $45.0M | 4% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
